Imagine this: you're taking medication for rheumatoid arthritis (RA), expecting it to ease your pain and swelling. But what if we told you that some of these drugs could potentially increase your risk of cancer? A major study called the Oral Rheumatoid Arthritis Trial Surveillance found that people with RA who took a drug named tofacitinib had a higher chance of developing cancer compared to those on another type of drug called tumor necrosis factor inhibitors (TNFis). Interestingly, most of this research was done outside the United States, so we're not sure if the same applies to Americans with RA.

There are various types of RA drugs, each working differently in your body to fight the disease. TNFis, non-TNFis, and Janus kinase inhibitors (JAKis) are some examples. While they help manage RA, they might also have different effects on your overall health, including cancer risks.

Having RA alone raises your cancer risk, so adding medication to the mix makes things complex. Doctors must balance the benefits of these drugs against the potential risks.

If you're an RA patient, it's crucial to chat with your doctor about your medication's possible side effects. They can help you understand the risks and make informed decisions about your health. Remember, everyone's health journey is unique, and what works for one person might not work for you.

Medicine and Cancer: What RA Patients Need to Know

Actions